The Clozapine REMS website at https://www.newclozapinerems.com/home has been updated to reflect that “Effective June 13, 2025, FDA has officially eliminated the clozapine REMS, and all REMS operations have ceased.” In other clozapine news, AAPP is pleased to announce we have been awarded grant funding from the Schizophrenia and Psychosis Action Alliance to develop a complimentary clozapine educational series for healthcare professionals anticipated to launch no later than early November 2025. You can share your excitement and support by signing up for information from S&PAA at their website.